Insider filing · AXSM
Herriot Tabuteau
Chief Executive Officer
profile →
Axsome Therapeutics, Inc.
AXSM · Healthcare · 34 filings in 24 months
ticker →
Herriot Tabuteau sold $21.8M of Axsome Therapeutics (AXSM)
Executed Nov 3 2025, disclosed Nov 5 2025, 2 days later.
Value, as filed
$21.8M
163,939 sh across 3 lots
Executed
Nov 3 2025
the trade date, as filed
Disclosed
Nov 5 2025
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
HTHerriot Tabuteau (Chief Executive Officer) filed 8 Form 4 reports in the trailing twelve months (0 purchases, 8 sales), most often in Axsome Therapeutics, Inc. (AXSM). The largest single filing was $23.9M of AXSM (139,414 sh across 3 lots, as filed), executed Jan 5.
The name
AXSMHealthcare · Axsome Therapeutics, Inc., a biopharmaceutical company, develops and delivers novel therapies for the management of central nervous system…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Herriot Tabuteau in AXSM
AXSMSALE
Axsome Therapeutics, Inc.
$10.5M49,664 sh across 2 lots
Exec Aug 5
Filed Aug 7 · 7:00 PM ET AXSMSALE Axsome Therapeutics, Inc. $11.9M
49,666 sh × $240.25
Exec Jul 1
Filed Jul 1 · 7:30 PM ET AXSMSALE Axsome Therapeutics, Inc. $12.0M
49,670 sh × $241.01
Exec Jun 9
Filed Jun 9 · 5:30 PM ET AXSMSALE Axsome Therapeutics, Inc. $6.0M
32,410 sh × $185.60
Exec Feb 2
Filed Feb 2 · 5:30 PM ET AXSMSALE Axsome Therapeutics, Inc. $23.9M
139,414 sh across 3 lots
Exec Jan 5
Filed Jan 7 · 5:30 PM ET AXSMSALE Axsome Therapeutics, Inc. $11.6M
79,973 sh across 3 lots
Exec Dec 2 2025
Filed Dec 4 2025 · 5:30 PM ET AXSMSALE Axsome Therapeutics, Inc. $5.4M
45,384 sh across 3 lots
Exec Oct 6 2025
Filed Oct 8 2025 · 5:30 PM ET AXSMSALE Axsome Therapeutics, Inc. $7.4M
62,880 sh across 3 lots
Exec Sep 12 2025
Filed Sep 16 2025 · 5:30 PM ET